PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,198,000 | +126.5% | 51,933 | 0.0% | 0.02% | +100.0% |
| Q3 2020 | $529,000 | -31.7% | 51,933 | 0.0% | 0.01% | -47.8% |
| Q2 2020 | $774,000 | +22.3% | 51,933 | 0.0% | 0.02% | -23.3% |
| Q1 2020 | $633,000 | -20.8% | 51,933 | +2.9% | 0.03% | +30.4% |
| Q4 2019 | $799,000 | +29.9% | 50,460 | 0.0% | 0.02% | -4.2% |
| Q3 2019 | $615,000 | – | 50,460 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|